logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Codiak Biosciences, Inc.

Calculating rank
USPTO Granted Patents = 14


Trademarks = 2

Forward Citations = 65

Loading Chart...
Loading Chart...

30 inventors (with patents filed for the assignee):

goldMedal Douglas E Williams (6 out of 18 patents)

silverMedal Jan Lötvall (5 out of 6 patents)

bronzeMedal John D Kulman (4 out of 21 patents)

4.  Sriram Sathyanarayanan (3 out of 10 patents)

5.  Ke Xu (3 out of 9 patents)

6.  Hadi Valadi (3 out of 4 patents)

7.  Kevin P Dooley (3 out of 6 patents)

8.  Rane A Harrison (3 out of 6 patents)

9.  Nuruddeen D Lewis (2 out of 4 patents)

10.  Russell E McConnell (2 out of 4 patents)

11.  Damian J Houde (2 out of 6 patents)

12.  Nikki Ross (2 out of 6 patents)

13.  Sonya Haupt (2 out of 4 patents)

14.  Jonas Andrej Nilsson (2 out of 2 patents)

15.  Yu Zhou (1 out of 3 patents)


14 patents:

1. 12766110 - EXTRACELLULAR VESICLES COMPRISING STING-AGONIST (2026-10-20),
2. 12746291 - METHODS OF LOADING EXTRACELLULAR VESICLES (2026-09-29),
3. 12648907 - MEMBRANE PROTEIN SCAFFOLDS FOR EXOSOME ENGINEERING (2026-06-09),
4. 12622876 - METHODS OF SUPPRESSING DELIVERY OF EXOSOMES TO LIVER AND SPLEEN (2026-05-12),
5. 12616712 - STING AGONIST COMPRISING EXOSOMES FOR TREATING NEUROIMMUNOLOGICAL DISORDERS (2026-05-05),
6. 11679164 - Preparation of therapeutic exosomes using membrane proteins (2023-06-20),
7. 11512315 - Methods and compositions for macrophage polarization (2022-11-29),
8. 10723782 - Exosomes for immuno-oncology and anti-inflammatory therapy (2020-07-28),
9. 10695443 - Exosome transfer of nucleic acids to cells (2020-06-30),
10. 10370663 - Delivery of therapeutic agent (2019-08-06),
11. 10195290 - Preparation of therapeutic exosomes using membrane proteins (2019-02-05),
12. 9889210 - Exosome transfer of nucleic acids to cells (2018-02-13),
13. 9856477 - Delivery of therapeutic agent (2018-01-02),
14. 9629929 - Exosome transfer of nucleic acids to cells (2017-04-25),
Company Overview
Codiak Biosciences, Inc. is a biotechnology company based in Cambridge, MA, specializing in the development of exosome-based therapeutics. The company focuses on harnessing the natural properties of exosomes to create innovative treatments for various diseases, including cancer and genetic disorders. Codiak's proprietary platforms enable the engineering of exosomes for targeted delivery of therapeutics, positioning the company at the forefront of advancements in drug delivery systems and precision medicine.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

Codiak Biosciences, Inc. USPTO Patent Assignee Logo
14 Patents

#182 in Cambridge, MA

#1,364 in Massachusetts

#22,344 in US

#42,312 in the World

Cambridge, MA (US)
Cambridge, MA, United States of America

Codiak Biosciences, Inc.

Forward Citations = 65

30 inventors:

goldMedal Douglas E Williams (6 out of 18 patents)

silverMedal Jan Lötvall (5 out of 6 patents)

bronzeMedal John D Kulman (4 out of 21 patents)

4.  Sriram Sathyanarayanan (3 out of 10 patents)

5.  Ke Xu (3 out of 9 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Codiak Biosciences, Inc.. Retrieved from https://idiyas.com/company/codiak-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…